// App-Quantinova.ai

4336 : Spliceosome inhibition as a novel therapeutic option in acute leukemia

Researchers

Presenter

  • Anna Wojtuszkiewicz

Principal Investigators

  • Rocco Sciarrillo

  • Gerrit Jansen

  • Yehuda G. Assaraf

  • Kazunori Koide

  • Robert K. Bressin

  • Upamanyu Basu

  • Edwin Sonneveld

  • Godefridus J. Peters

  • Gertjan J L Kaspers

  • Jacqueline Cloos

Medical Centers

  • Academic Medical Center, Amsterdam, Netherlands

  • Technion - Israel Institute of Technology, Amsterdam, Israel

  • University of Pittsburgh, Pittsburgh, PA

  • Dutch Childhood Oncology Group, The Hague, Netherlands.

Locations

  • United States

  • Israel

  • Netherlands

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

  • Hematological malignancies

  • Acute myelocytic leukemia

  • Acute Leukemia

  • Solid malignancies

Biomarkers

  • Breakpoint Cluster Region

Drug/Treatment

  • Glucocorticoid

  • Methotrexate

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved